Categories: Business

Cango Inc. Announces Completion of Secondary Acquisition and Appointment of New Leadership Team

HONG KONG, July 23, 2025 /PRNewswire/ — Cango Inc. (NYSE: CANG) today announced its transformation into a global Bitcoin miner with the appointment of a new Board of Directors (the “Board”) and senior management team with deep expertise in digital-asset infrastructure, finance, and energy investments.

- Advertisement -

On July 23, 2025, the Board appointed (i) Mr. Xin Jin as Chairman of the Board and Non-Executive Director, (ii) Mr. Peng Yu as CEO and Director, (iii) Mr. Chang-Wei Chiu as Director, (iv) Mr. Yongyi Zhang as CFO and (v) Mr. Simon Ming Yeung Tang as CIO To strengthen governance, the Board also appointed (i) Mr. Chi Ming Lee, Independent Director, as a member of the Compensation Committee and Nominating and Corporate Governance Committee, (ii) Mr. Yanjun Lin, Independent Director, as Chairman of the Compensation Committee and member of the Nominating and Corporate Governance Committee, and (iii) Mr. Haitian Lu as Chairman of the Nominating and Corporate Governance Committee and member of the Compensation Committee. The Board also accepted the resignations of Mr. Xiaojun Zhang as Director and Chairman, and Mr. Jiayuan Lin as CEO, Interim CFO, and Director. All changes are effective immediately.

- Advertisement -

Mr. Peng Yu, CEO and Director, commented, “This leadership team gives Cango the right mix of skills to execute our next phase of growth. Having successfully transformed into a Bitcoin miner, we have already made remarkable progress in the past 7 months by becoming one of the largest Bitcoin miners in the world. With a strong balance sheet and clear long-term vision, our collective experience will help us scale beyond the 50 EH/s already deployed, not only safeguarding but strategically growing our treasury of more than 4,000 Bitcoins to maximize shareholder value. We will begin developing sustainable, high-performance computing opportunities while strategically expanding upstream into dedicated power resources especially green energy that will create lasting value for shareholders and drive further growth.”

- Advertisement -

Mr. Xiaojun Zhang and Mr. Jiayuan Lin resigned as co-founders coinciding with a secondary sale of 10 million Class B shares to Enduring Wealth Capital Limited for US$70 million. They converted their remaining Class B shares into Class A shares, now holding 18.54% of total outstanding shares and 12.07% of voting power. Enduring Wealth Capital Limited now holds about 2.82% of outstanding shares and 36.73% of voting power..

- Advertisement -

Full article: https://ir-image.cangoonline.com/ir-documents/2025-07-23_Cango%20Inc.%20Announces%20Completion%20of%20Secondary%20Acquisition%20and%20Appointment%20of%20New%20Leadership%20Team.pdf

- Advertisement -

Investor Relations Contact

- Advertisement -

Juliet YE, Head of Communications
Cango Inc.
Email: ir@cangoonline.com 

- Advertisement -

Logo – https://mma.prnewswire.com/media/2675436/CANG_LOGO_Logo.jpg

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/cango-inc-announces-completion-of-secondary-acquisition-and-appointment-of-new-leadership-team-302512065.html

- Advertisement -
PRNW Agency

Recent Posts

Sri Adhikari Brothers Television Network Ltd. (SABTNL) Charts New Technology-Led Future with Strategic Transformation and 50 MW AI & Green Data Centre Proposal

Sri Adhikari Brothers Television Network Ltd. (SABTNL) (BSE 530943) (NSE: SABTNL) (ISIN: INE416A01044), today announced…

20 minutes ago

FITUR 2026 Expands Its Travel Technology Area by 50%, Strengthening Its Role as the Leading Hub for Innovation-Tourism Dialogue

Located in the new Knowledge Hub (Hall 12), this area brings together startups and firms…

1 hour ago

Vantage Wins ‘Best Mobile Trading App – APAC’ at the UF Awards APAC 2025

PORT VILA, Vanuatu, Nov. 25, 2025 /PRNewswire/ -- Vantage, the leading multi-asset broker, is delighted…

1 hour ago

Novartis data underscore pioneering scientific innovation in Hematology and Oncology at ASH and SABCS

Positive results from ianalumab pivotal Phase III trial in ITP patients previously treated with corticosteroids…

5 hours ago

Press Release: Sanofi and Regenerons Dupixent approved as the first targeted medicine in the EU in over a decade for chronic spontaneous urticaria

Sanofi and Regeneron’s Dupixent approved as the first targeted medicine in the EU in over…

5 hours ago

GigaDevice Launches GD25NX Series xSPI NOR Flash with Dual-Voltage Design

BEIJING--(BUSINESS WIRE)--#Automotive--GigaDevice, a leading semiconductor company specializing in Flash memory, 32-bit microcontrollers (MCUs), sensors, and…

5 hours ago